Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Leukemia and lymphoma (BASKET).php on line 2
Leukemia and lymphoma (BASKET)
LE WE PMID CA
Leukemia and lymphoma (BASKET)6006Leukaemie und Lymphom (allg)

JAK STAT

Leukemia and lymphoma (BASKET)

Neoplasia (Inherited)

Neoplasia (Tumor biology and immunology)

2009  
1
Advances in understanding and management of myeloproliferative neoplasms.
[19369682] CA Cancer J Clin 59(3): 171-91 (2009)
2005  
2
The biology of human lymphoid malignancies revealed by gene expression profiling.
[16102574] Adv Immunol 87(-): 163-208 (2005)
2010  
3
Molecular basis and clonal evolution of myeloproliferative neoplasms.
[20378573] Haematologica 95(4): 526-9 (2010)
2008  
4
Molecular pathophysiology of Philadelphia-negative myeloproliferative disorders: beyond JAK2 and MPL mutations.
[18591622] Haematologica 93(7): 972-6 (2008)
2009  
5
Molecular basis of myelodysplastic/myeloproliferative neoplasms.
[19996113] Haematologica 94(12): 1634-8 (2009)
2010  
6
Hereditary myeloproliferative disorders.
[20065077] Haematologica 95(1): 6-8 (2010)
2009  
7
Therapy-related myeloid neoplasms.
[19336749] Haematologica 94(4): 454-9 (2009)
2006  
8
Atypical myeloproliferative disorders: diagnosis and management.
[16610578] Mayo Clin Proc 81(4): 553-63 (2006)
2006  
9
Diagnostic assays for the JAK2 V617F mutation in chronic myeloproliferative disorders.
[16707363] Am J Clin Pathol 125(5): 651-3 (2006)
2010  
10
Molecular pathology of myeloproliferative neoplasms.
[20231614] Am J Clin Pathol 133(4): 602-15 (2010)
2009  
11
Therapy-related myeloid neoplasms.
[19687318] Am J Clin Pathol 132(3): 410-25 (2009)
2005  
12
The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis.
[16007902] Mayo Clin Proc 80(7): 947-58 (2005)
2010  
13
PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms.
[20660931] Clin Med Res 8(2): 84-8 (2010)
2009  
14
Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies.
[19344392] Br J Haematol 145(5): 569-80 (2009)
2010  
15
Vascular endothelial growth factor-related pathways in hemato-lymphoid malignancies.
[20508816] J Oncol 2010(-): 729725 (2010)
2009  
16
A novel role for the marrow microenvironment in initiating and sustaining hematopoietic disease.
[19063690] Expert Opin Biol Ther 9(1): 21-8 (2009)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Leukemia and lymphoma (BASKET).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Leukemia and lymphoma (BASKET).php on line 92